Histamine Dihydrochloride

CHEMBL1533310 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
184.1 g/mol
LogP
Phase
4

This is the dihydrochloride salt form of histamine, used in an approved combination therapy with interleukin-2 for the treatment of acute myeloid leukemia in remission. It works by protecting natural killer cells and T-cells from reactive oxygen species produced by monocytes, thereby enhancing the anti-cancer immune response. The salt form is used for pharmaceutical stability.

Peso molecular

184,0600 g/mol

TPSA

54,70 Ų

Áreas terapéuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cl.Cl.NCCc1c[nH]cn1

InChI

InChI=1S/C5H9N3.2ClH/c6-2-1-5-3-7-4-8-5;;/h3-4H,1-2,6H2,(H,7,8);2*1H

Molecular Formula

C5H11Cl2N3

HBD / HBA

4 / 2

Enlaces Rotables

2

Átomos Pesados

10

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

This is the dihydrochloride salt form of histamine, used in an approved combination therapy with interleukin-2 for the treatment of acute myeloid leukemia in remission. It works by protecting natural killer cells and T-cells from reactive oxygen species produced by monocytes, thereby enhancing the anti-cancer immune response. The salt form is used for pharmaceutical stability.

Yes, Histamine Dihydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1533310. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5818. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.